Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Upfill Brown, Alexander M ^a   Voorman, Arend ^b   Chabot Couture, Guillaume ^a   Shuaib, Faisal ^c,d   Lyons, Hil M ^a  

^a INSTITUTE FOR DISEASE MODELING   (United States)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

^c Ministry of Federal Health Nigeria   (Nigeria)

^d National Polio Emergency Operations Center   (Nigeria)

Author keywords

Campaigns; Coverage; Eradication; Hierarchical modeling; Immunity; Nigeria; Polio; Supplementary immunization activities

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; BAYES THEOREM; CHILD; CIRCULATING VACCINE DERIVED POLIOVIRUS; CONTROLLED STUDY; DATA BASE; DISEASE ERADICATION; DRUG EFFICACY; HUMAN; HUMAN POLIOVIRUS 1; HUMAN POLIOVIRUS 2; IMMUNITY; INFANT; LOT QUALITY ASSURANCE SAMPLING; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; POPULATION IMMUNITY; PRESCHOOL CHILD; PROGRAM EFFECTIVENESS; PROGRAM EVALUATION; PUBLIC HEALTH CAMPAIGN; VACCINATION; VALIDATION STUDY; VIRUS IMMUNITY; WILD POLIOVIRUS; AFRICA; IMMUNOLOGY; PROSPECTIVE STUDY;

AFRICA; BAYES THEOREM; HUMANS; NIGERIA; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; PROSPECTIVE STUDIES; VACCINATION;

EID: 84962861305     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0600-z     Document Type: Article

References (23)

1. Sutter RW, Maher C. Mass vaccination campaigns for polio eradication: an essential strategy for success. Curr Top Microbiol Immunol. 2006;304:195-220.
2. Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva: WHO; 2013.
3. World Health Organization. Global Guidelines: Independent Monitoring of Polio Supplementary Immunization Activities (SIA). Geneva: WHO; 2014.
4. World Health Organization. Assessing vaccination coverage levels using clustered Lot Quality Assurance Sampling: field manual version edited for the Global Polio Eradication Initiative (GPEI). Geneva: WHO; 2012.
5. Brown AE, Okayasu H, Nzioki MM, Wadood MZ, Chabot-Couture G, Quddus A, et al. Lot quality assurance sampling to monitor supplemental immunization activity quality: an essential tool for improving performance in polio endemic countries. J Infect Dis. 2014;210(Suppl):S333-40.
6. Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, et al. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal. 2013;33:664-79.
7. Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet. 2007;369:1356-62.
8. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Abanida EA, Koleosho-Adelekan T, et al. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med. 2008;359:1666-74.
9. Upfill-Brown AM, Lyons HM, Pate M, Shuaib F, Baig S, Hu H, et al. Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med. 2014;12:92.
10. Levitt A, Diop OM, Tangermann RH, Paladin F, Kamgang JB, Burns CC, et al. Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63:356-61.
11. Plotkin SA, Orenstein W, Offit PA. Poliovirus vaccine-live, Vaccines. 6th ed. Philadelphia: Saunders; 2013. p. 598-645.
12. Rue H, Held L. Gaussian Markov Random Fields: Theory and Applications. Boca Raton: CRC Press; 2005.
13. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B (Statistical Methodol). 2002;64:583-639.
14. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. https://www.r-project.org/.
15. Stan Development Team. Stan: A C++ Library for Probability and Sampling, Version 2.8.0. 2015. http://mc-stan.org/.
16. Stan Development Team. RStan: the R interface to Stan, Version 2.5.0. 2014. http://mc-stan.org/.
17. Global Polio Eradication Initiative. Preparing for the Withdrawal of All Oral Polio Vaccines (OPVs): Replacing Trivalent OPV (tOPV) with Bivalent OPV (bOPV). 2015. http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/OPVswitch-briefing-note-Feb2015.pdf. Accessed 21 Oct 2015.
18. Touray K, Mkanda P, Tegegn SG, Nsubuga P, Erbeto TB, Banda R, et al. Tracking vaccination teams during polio campaigns in northern Nigeria by use of geographic information system technology: 2013-2015. J Infect Dis. 2015. Ahead of print.
19. Barau I, Zubairu M, Mwanza MN, Seaman VY. Improving polio vaccination coverage in Nigeria through the use of geographic information system technology. J Infect Dis. 2014;210(Suppl):S102-10.
20. World Health Organization. Polio eradication & endgame strategic plan 2013-2018: financial resource requirements. Geneva: WHO; 2014.
21. Etsano A, Gunnala R, Shuaib F, Damisa E, Mkanda P, Ticha JM, et al. Progress toward poliomyelitis eradication--Nigeria, January 2014-July 2015. MMWR Morb Mortal Wkly Rep. 2015;64:878-82.
22. Polio this week as of 21 October 2015. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 23 Oct 2015.
23. Mangal TD, Aylward RB, Mwanza M, Gasasira A, Abanida E, Pate MA, et al. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study. Lancet Glob Heal. 2014;2:e90-7.